Nature Communications (Dec 2022)
A conformation-specific nanobody targeting the nicotinamide mononucleotide-activated state of SARM1
Abstract
SARM1 is a key player in axon degeneration. Here, the authors generate a nanobody, which specifically recognizes the NMN-bound state of SARM1 and helps resolve the SARM1 structure in an intermediate state of activation.